Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pharmacology|March 6, 2003
Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjectsJules I Schwartz, Saurabh Mukhopadhyay, Arturo G Porras, et al.Journal of Clinical Pharmacology|February 28, 2009
Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptomsVictor Dishy, Fang Liu, David L Ebel, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semenJ I Schwartz, W K Tanaka, D Z Wang, et al.Physical Review Letters|October 13, 2007
Control of magnetic anisotropy in (Ga,Mn)as by lithography-induced strain relaxationJ Wenisch, C Gould, L Ebel, et al.Journal of Clinical Pharmacology|January 6, 2001
Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteersJ I Schwartz, M De Smet, P J Larson, et al.Biopharmaceutics & Drug Disposition|July 1, 1994
The bioavailability and nonlinear pharmacokinetics of MK-679 in humansH Cheng, J I Schwartz, C Lin, et al.Journal of Clinical Pharmacology|April 1, 1995
Novel oral medication delivery system for famotidineJ I Schwartz, K C Yeh, M L Berger, et al.Phytokeys|March 8, 2024
Revised checklist of endemic vascular plants of KazakhstanSerik A Kubentayev, Daniyar T Alibekov, Yuri V Perezhogin, et al.Journal of Clinical Pharmacology|October 5, 2001
Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patientsJ I Schwartz, N G Agrawal, P H Wong, et al.Journal of Clinical Pharmacology|October 12, 2000
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteersA Van Hecken, J I Schwartz, M Depré, et al.Pageof 3